BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25080434)

  • 21. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation.
    Lu J; Pierron A; Ravid K
    Cancer Res; 2003 Oct; 63(19):6413-23. PubMed ID: 14559831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro.
    Chen J; Thompson LU
    Breast Cancer Res Treat; 2003 Jul; 80(2):163-70. PubMed ID: 12908819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
    Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
    Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.
    Wang L; Zhou X; Zhou T; Ma D; Chen S; Zhi X; Yin L; Shao Z; Ou Z; Zhou P
    J Cancer Res Clin Oncol; 2008 Mar; 134(3):365-72. PubMed ID: 17671792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway.
    Shen X; Qian L; Falzon M
    Exp Cell Res; 2004 Apr; 294(2):420-33. PubMed ID: 15023531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
    Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
    Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel taspine derivative, HMQ1611, suppresses adhesion, migration and invasion of ZR-75-30 human breast cancer cells.
    Zhan Y; Wang N; Liu C; Chen Y; Zheng L; He L
    Breast Cancer; 2014 May; 21(3):334-40. PubMed ID: 22875642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purinergic Receptor Expression and Cellular Responses to Purinergic Agonists in Human Prostate Cancer Cells.
    Lertsuwan K; Peters W; Johnson L; Lertsuwan J; Marwa I; Sikes RA
    Anticancer Res; 2017 Feb; 37(2):529-537. PubMed ID: 28179298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin.
    Evans BA; Elford C; Pexa A; Francis K; Hughes AC; Deussen A; Ham J
    J Bone Miner Res; 2006 Feb; 21(2):228-36. PubMed ID: 16418778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.
    Kutryb-Zajac B; Koszalka P; Mierzejewska P; Bulinska A; Zabielska MA; Brodzik K; Skrzypkowska A; Zelazek L; Pelikant-Malecka I; Slominska EM; Smolenski RT
    J Cell Mol Med; 2018 Dec; 22(12):5939-5954. PubMed ID: 30291675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway.
    Zhu H; Liu XW; Cai TY; Cao J; Tu CX; Lu W; He QJ; Yang B
    J Pharmacol Exp Ther; 2010 Aug; 334(2):489-99. PubMed ID: 20472666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.
    Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG
    Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells.
    Wang L; Ling Y; Chen Y; Li CL; Feng F; You QD; Lu N; Guo QL
    Cancer Lett; 2010 Nov; 297(1):42-8. PubMed ID: 20580866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.